Cheryl Platzman Weinstock is an award–winning journalist who reports about health and science research and its impact on society. Her investigative pieces have brought attention to mental health, medical ethics issues and the medical research gender gap. She also writes for the Metro desk of The New York Times.
Cheryl Platzman Weinstock
From this contributor
The deep emotional ties between depression and autism
Autistic people are four times as likely to experience depression over the course of their lives as their neurotypical peers. Yet researchers know little about why, or how best to help.
The deep emotional ties between depression and autism
By
Cheryl Platzman Weinstock
31 July 2019 | 14 min read
The hidden danger of suicide in autism
Many people with autism entertain thoughts of suicide and yet show few obvious signs of their distress. Some scientists are identifying risks — and solutions — unique to autistic individuals.
The hidden danger of suicide in autism
By
Cheryl Platzman Weinstock
8 August 2018 | 16 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read